Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis.
J L DammanEduardo A RodriguezA H AliC W BunessK L CoxE J CareyKeith D LindorPublished in: Alimentary pharmacology & therapeutics (2018)
Vancomycin is one of the most studied antibiotics used in the treatment of PSC with promising results. There is not currently sufficient evidence to support treatment recommendations. Further research is needed to establish if vancomycin is a PSC treatment.